Skip to content
10-K

Annual Report

CymaBay Therapeutics, Inc.

0001193125-23-077859

← back to feed
Filed
Mar 23, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 15, 2023 97.29M sh
Cash And Equivalents FY 2022 · Dec 31, 2021 $125.81M
Current Liabilities FY 2022 · Dec 31, 2021 $18.37M
Total Liabilities FY 2022 · Dec 31, 2021 $69.38M
Current Assets FY 2022 · Dec 31, 2021 $191.1M
Total Assets FY 2022 · Dec 31, 2021 $202.32M